Health

GSK says tests show Vir antibody drug works against Omicron

GlaxoSmithKline on Thursday said that a pre-clinical analysis of the antibody-based COVID-19 therapy it is developing with US partner Vir has indicated that the drug also works against the new Omicron variant.

Further tests will be carried out on the sotrovimab therapy to firm up the results, GSK said in a statement.

For all the latest headlines follow our Google News channel online or via the app.

UAE reports its first case of COVID-19 variant Omicron

Fauci: First US case of COVID-19 omicron variant identified

Health

Syria: WHO Regional Director calls for greater investment in health sector

Failure to invest in the health of the Syrian people will only deepen instability in the war-ravaged country and pose threats to regional and global security, a senior official with the World Health Organization (WHO) has said.

Health

World News in Brief: Vaccine ‘patches’ trial shows promise, lowering catheter infection risk, Guantanamo detainee facing revictimisation

Few enjoy having injections and if you have children, you probably like them even less when it’s time for their mandated vaccine shots.

Health

No sign yet of H5N1 bird flu spreading between humans, says WHO chief

The H5N1 avian influenza virus has so far shown no signs of adapting to allow human to human transmission, the UN health agency said on Wednesday, urging continued surveillance.